Reginald Seeto - Jun 25, 2021 Form 4 Insider Report for CareDx, Inc. (CDNA)

Role
President & Chief Executive Officer, Director
Signature
/s/ Reginald Seeto
Stock symbol
CDNA
Transactions as of
Jun 25, 2021
Transactions value $
-$1,242,378
Form type
4
Date filed
8/17/2021, 06:59 PM
Previous filing
Jun 25, 2021
Next filing
Jul 7, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDNA Common Stock Options Exercise $79.1K +3.25K +2.45% $24.35 136K Jun 25, 2021 Direct F1
transaction CDNA Common Stock Options Exercise $165K +5.96K +4.4% $27.72 142K Jun 25, 2021 Direct F1
transaction CDNA Common Stock Sale -$876K -9.21K -6.51% $95.15* 132K Jun 25, 2021 Direct F1, F2
transaction CDNA Common Stock Options Exercise $37.6K +1.55K +1.17% $24.35 134K Jun 28, 2021 Direct F1
transaction CDNA Common Stock Options Exercise $317K +11.7K +8.71% $27.17 146K Jun 28, 2021 Direct F1
transaction CDNA Common Stock Sale -$813K -8.52K -5.85% $95.42* 137K Jun 28, 2021 Direct F1, F3
transaction CDNA Common Stock Sale -$452K -4.69K -3.42% $96.34* 132K Jun 28, 2021 Direct F1, F4
transaction CDNA Common Stock Options Exercise $300K +10.8K +8.17% $27.72 143K Aug 11, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDNA Employee Stock Option (right to buy) Options Exercise $0 -3.25K -9.22% $0.00 32K Jun 25, 2021 Common Stock 3.25K $24.35 Direct F1, F5
transaction CDNA Employee Stock Option (right to buy) Options Exercise $0 -5.96K -8.19% $0.00 66.9K Jun 25, 2021 Common Stock 5.96K $27.72 Direct F1, F6
transaction CDNA Employee Stock Option (right to buy) Options Exercise $0 -1.55K -4.83% $0.00 30.4K Jun 28, 2021 Common Stock 1.55K $24.35 Direct F1, F5
transaction CDNA Employee Stock Option (right to buy) Options Exercise $0 -11.7K -44.59% $0.00 14.5K Jun 28, 2021 Common Stock 11.7K $27.17 Direct F1, F7
transaction CDNA Employee Stock Option (right to buy) Options Exercise $0 -10.8K -16.18% $0.00 56K Aug 11, 2021 Common Stock 10.8K $27.72 Direct F1, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.00 to $90.37, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.00 to $96.00, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.10 to $96.53, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
F5 1/4th of the shares subject to the option vested on January 29, 2021 and 1/48th of the shares subject to the option vest monthly thereafter.
F6 25% of the shares subject to the option vested on November 26, 2019 and 1/48th of the shares subject to the option vest monthly thereafter.
F7 1/4th of the shares subject to the option vested on February 4, 2019 and 1/48th of the shares subject to the option vest monthly thereafter.

Remarks:

President & Chief Executive Officer